Capital Market Strategies LLC Pfizer Inc Transaction History

Capital Market Strategies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$25.89 - $29.73 $89,346 - $102,598	-3,451 Reduced 28.27%	8,755 $242,000
Q4 2023 Jan 08, 2024	SELL	$26.13 - $33.94 $177,292 - $230,282	-6,785 Reduced 35.73%	12,206 $351,000
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $49,482 - $57,840	-1,542 Reduced 7.51%	18,991 $629,000
Q2 2023 Jul 06, 2023	SELL	$36.12 - $41.79 $82,859 - $95,866	-2,294 Reduced 10.05%	20,533 $753,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $125,299 - $163,121	-3,181 Reduced 12.23%	22,827 $931,000
Q4 2022 Jan 17, 2023	BUY	$41.75 - $54.5 $7,765 - $10,137	186 Added 0.72%	26,008 $0
Q3 2022 Oct 14, 2022	SELL	$43.76 - $53.42 $17,591 - $21,474	-402 Reduced 1.53%	25,822 $1.13 Million
Q2 2022 Jul 11, 2022	BUY	$46.53 - $55.17 $1,814 - $2,151	39 Added 0.15%	26,224 $1.38 Million
Q1 2022 Apr 18, 2022	SELL	$45.75 - $56.69 $80,428 - $99,661	-1,758 Reduced 6.29%	26,185 $1.36 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $1.15 Million - $1.71 Million	27,943 New	27,943 $1.65 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Capital Market Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Market Strategies LLC with notifications on news.